The global immunoassay market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–7% over the ...
TETRAPHARM, a Copenhagen-based biopharmaceutical company focused on neuroscience, psychiatry, and metabolic disorders, today announced promising preclinical data for TPC-026, a novel investigational ...
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and period-to-period ...
According to MarketsandMarkets, the Proteomics Market is projected to grow from about USD 36.32 billion in 2025 to USD 65.78 billion by 2030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results